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Background: Little is known regarding relationships between hsCRP and lipoproteins other than LDL-C, particularly HDL-C which has both anti-
inflammatory and cholesterol mediating effects. This exploratory analysis assessed associations between hsCRP and lipid factors in a study of older 
(>65 yrs) patients with moderate/high CVD risk, treated with ezetimibe/simvastatin (E/S) or atorvastatin (A).
Methods: Post hoc analysis of a multicenter, randomized, double blind 12 wk study. Correlations were assessed in 1054 patients with both 
baseline and 12 wk hsCRP ≤10mg/L, pooled across doses of E/S (10/20, 10/40 mg) and A (10, 20, 40 mg), and pooled E/S+A treatments.
Results: Correlations between baseline levels of hsCRP with LDL-C, non-HDL-C and ApoB were weak and non-significant in the E/S and A and 
pooled E/S+A groups (table). After 12 wks of treatment these correlations were significantly higher in all groups. In contrast, HDL-C was negatively 
and significantly correlated with hsCRP in the A and pooled E/S+A groups at baseline and in all groups at 12 wks. Associations between changes in 
hsCRP and these lipid factors were low but significant for pooled E/S+A, and also for LDL-C and non-HDL-C in the A group and HDL-C in the E/S and 
A groups.
Conclusions: Relationships between hsCRP and lipid factors were weak at baseline and improved somewhat after treatment in older patients. 
HDL-C was negatively and consistently correlated with baseline and 12 wk hsCRP levels, as well as with therapy induced changes in HDL-C and 
hsCRP. 
Relationship
hsCRP and
Spearman Correlation Coefficients
Baseline levels 12 wk levels Changes at 12 wks
Pooled E/S Pooled A
Pooled
E/S+A
Pooled E/S Pooled A
Pooled
E/S+A
Pooled E/S Pooled A
Pooled
E/S+A
LDL-C 0.018 -0.067 -0.034 0.154‡ 0.102† 0.110§ 0.061 0.082† 0.078†
HDL-C -0.091 -0.110‡ -0.103§ -0.128‡ -0.133§ -0.132§ -0.166§ -0.092† -0.117§
non-HDL-C 0.051 -0.004 0.018 0.185§ 0.138§ 0.138§ 0.094 0.078† 0.085‡
ApoB 0.072 -0.001 0.029 0.177§ 0.122‡ 0.133§ 0.092 0.077 0.083‡
†p<0.05, ‡p<0.01, §p<0.001 for baseline levels, 12 wk levels and change at 12 wks; Pooled E/S=ezetimibe/simvastatin 10/20 and 10/40 mg 
(n=419 for paired endpoints); Pooled A=atorvastatin 10, 20, 40 mg (n ≥627 for paired endpoints); pooled E/S+A (n ≥1046 for paired endpoints)
